Melt Pharmaceuticals raises $24 million for drug development

Melt Pharmaceuticals, a spin-off of Harrow Inc., is looking to change the game in pain management for medical procedures. Here's how it's using $24 million in funding to do that and what's next for its drug development.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news